Inc.

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

Myriad Genetics Hires Five Senior Executives to Advance Business Growth Plans

New leaders to elevate product portfolio, customer-centric business capabilities, and sales and marketing execution SALT LAKE CITY, Dec. 19 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the arrival of five senior executives to help further strengthen the company product roadmap and improve …

Myriad Genetics Hires Five Senior Executives to Advance Business Growth Plans Read More »

How daredevil drones find nearly extinct plants hidden in cliffs

How daredevil drones find nearly extinct plants hidden in cliffs

Dec 10 (Reuters) – Ben Nyberg stood on a sharp ridge along Hawaii’s Na Pali coast, his eyes scanning the leafy nooks of nearby red rock ridges. It was quiet, save for the faint hum of a drone flying among flocks of curious white-tailed tropicbirds. Nyberg aimed the drone closer to the opposite ridge, scanning …

How daredevil drones find nearly extinct plants hidden in cliffs Read More »

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022

SAN DIEGO, December 2, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today released demographic and clinical data from studies based on genetic screening of children with SCN8A– related epilepsies. Data was collected from over 17,000 patients through Invitee Corporation’s Behind the Seizure® Program, of which Neurocrine Biosciences is a …

Neurocrine Biosciences presents data on the demographic and clinical characteristics of pediatric patients with SCN8A-related epilepsy at AES 2022 Read More »

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment

A featured discussion sheds light on how the Combined Risk Score can lead to better breast cancer prevention and screening strategies. SALT LAKE CITY, Nov. 29, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc.., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced several new data presentations at the San Antonio Breast Cancer …

Myriad Genetics to Present New Data at San Antonio Breast Cancer Symposium, Showcasing Advances in Breast Cancer Risk Assessment and Treatment Read More »

PLANET FITNESS RAISE OVER $500,000 IN OCTOBER FUNDRAISER TO BENEFIT BOYS & GIRLS CLUBS OF AMERICA

PLANET FITNESS RAISE OVER $500,000 IN OCTOBER FUNDRAISER TO BENEFIT BOYS & GIRLS CLUBS OF AMERICA

Members, Team Members and Franchisees collectively achieve $8 million Milestone giving since 2016 in support of anti-bullying and pro-kindness efforts of The Judgment Free Generation® HAMPTON, NH, November 29, 2022 /PRNewswire/ — Planet Fitness, one of the largest and fastest growing franchisors and operators of fitness centers with more members than any other fitness brand, …

PLANET FITNESS RAISE OVER $500,000 IN OCTOBER FUNDRAISER TO BENEFIT BOYS & GIRLS CLUBS OF AMERICA Read More »